Announcements

Matthew Duffy, an officer and director of Neptune Insurance Holdings Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 88,000 shares of common stock on the NYSE.

Director B Lynne Parshall filed a Form 144 notice with the SEC on November 9, 2026, disclosing a proposed sale of 5,000 shares of Cytokinetics, Incorporated common stock on NASDAQ.

Robin Tomasello, an officer of SentinelOne, Inc., filed a Form 144 notice of proposed sale of 2,986 shares of common stock, with a notice date of November 9, 2026.

Schrodinger Inc officer Yvonne Tran filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 32,000 shares of common stock on NASDAQ under a Rule 10b5-1 plan.

Director Nancy Harris filed a Form 144 notice of proposed sale with the SEC on November 9, 2026, disclosing plans to sell 3,256 shares of Intapp Inc. common stock on NASDAQ.

Director Roger Anthony Carolin filed a Form 4 with the SEC on November 9, 2026, disclosing the exercise of a stock option covering 20,000 shares of Amkor Technology, Inc. common stock on November 5, 2026.

Kevin K. Engel, an officer and director of Amkor Technology, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 1,000 shares of Amkor common stock pursuant to Rule 144 under the Securities Act of 1933.